Rate My Professor Zhi Hong Jiang

Zhi-Hong Jiang is a Chair Professor and Vice President at Macau University of Science and Technology (MUST). He obtained his B.Sc. in 1987 and M.Sc. in 1990 from China Pharmaceutical University, Nanjing, China, and his Ph.D. in 1998 from Nagasaki University, Japan. His academic career began as Research Associate and Lecturer at China Pharmaceutical University from 1990 to 1994, followed by Research Assistant Professor at the School of Pharmaceutical Sciences, Nagasaki University from 1996 to 2001. He served as Postdoctoral Research Fellow in the Department of Biological Chemistry and Molecular Pharmacology at Harvard Medical School, USA, from 1999 to 2001. At Hong Kong Baptist University, School of Chinese Medicine, he progressed from Assistant Professor (2001-2005) to Associate Professor (2005-2008) and Professor (2008-2011). Upon joining MUST in 2011, he became Dean of the Macau Institute of Pharmaceutical and Health Applications (2011-2015), Deputy Director of the State Key Laboratory of Quality Research in Chinese Medicine (2011-2016), Chair Professor (2015-present), Vice President (2016-present), and Director of the State Key Laboratory of Mechanism and Quality of Chinese Medicine (2022-present). He also serves as Director of the Macau Institute for Applied Research in Medicine and Health.

Professor Jiang's research focuses on natural medicinal chemistry, metabolomics, Chinese medicine quality standards, bio-organic chemistry, chemical analysis of Chinese herbs, and modernization of Chinese medicine using spectroscopic, chromatographic, chemical biology, and metabolomic techniques. He has authored over 330 SCI papers in journals such as Nucleic Acids Research, Nature Communications, JACS, Analytical Chemistry, Organic Letters, and Molecular Therapy - Nucleic Acids, garnering more than 13,000 citations and an h-index of 67 (Google Scholar, 2024). Key publications include "The nature of the modification at position 3.7 of tRNA Phe correlates with acquired taxol resistance" (Nucleic Acids Res., 2021), "Full-Range Profiling of tRNA Modifications Using LC–MS/MS at Single-Base Resolution through a Site-Specific Cleavage Strategy" (Anal. Chem., 2020), and recent works on anti-inflammatory carabranolides and boswellianols. His honors include Young Distinguished Scholars by the National Natural Science Foundation of China (Overseas) in 2007, Chair Professor under the Changjiang Scholars Programme in 2014, and Member of the Chinese Pharmacopoeia Commission in 2022. He holds prominent roles as Vice President of the National Technical Committee of Standardization of Traditional Chinese Medicine, President of the Cross-Strait Scientific Collaboration Center for Chinese Medicine, and Vice President of the Macao Science and Technology Council.